PT2528617E - Interleucina-2 ou interferão-alfa para uso no tratamento da dependência de nicotina ou de alimentos - Google Patents
Interleucina-2 ou interferão-alfa para uso no tratamento da dependência de nicotina ou de alimentos Download PDFInfo
- Publication number
- PT2528617E PT2528617E PT117054726T PT11705472T PT2528617E PT 2528617 E PT2528617 E PT 2528617E PT 117054726 T PT117054726 T PT 117054726T PT 11705472 T PT11705472 T PT 11705472T PT 2528617 E PT2528617 E PT 2528617E
- Authority
- PT
- Portugal
- Prior art keywords
- interleukin
- interferon
- alpha
- treating nicotine
- food addiction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29913110P | 2010-01-28 | 2010-01-28 | |
| EP10151979 | 2010-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2528617E true PT2528617E (pt) | 2016-03-31 |
Family
ID=44318697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117054726T PT2528617E (pt) | 2010-01-28 | 2011-01-27 | Interleucina-2 ou interferão-alfa para uso no tratamento da dependência de nicotina ou de alimentos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9028808B2 (pt) |
| EP (1) | EP2528617B1 (pt) |
| DK (1) | DK2528617T3 (pt) |
| ES (1) | ES2565486T3 (pt) |
| PL (1) | PL2528617T3 (pt) |
| PT (1) | PT2528617E (pt) |
| WO (1) | WO2011092231A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10244793B2 (en) | 2005-07-19 | 2019-04-02 | Juul Labs, Inc. | Devices for vaporization of a substance |
| US10279934B2 (en) | 2013-03-15 | 2019-05-07 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| US10183061B2 (en) * | 2013-06-25 | 2019-01-22 | Icm (Institut Du Cerveau Et De La Moelle Epiniere) | Boosting Treg cells for treating Alzheimer disease and related disorders |
| US10076139B2 (en) | 2013-12-23 | 2018-09-18 | Juul Labs, Inc. | Vaporizer apparatus |
| US10159282B2 (en) | 2013-12-23 | 2018-12-25 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| USD842536S1 (en) | 2016-07-28 | 2019-03-05 | Juul Labs, Inc. | Vaporizer cartridge |
| AU2014369867A1 (en) | 2013-12-23 | 2016-06-16 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10058129B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Vaporization device systems and methods |
| USD825102S1 (en) | 2016-07-28 | 2018-08-07 | Juul Labs, Inc. | Vaporizer device with cartridge |
| US20160366947A1 (en) | 2013-12-23 | 2016-12-22 | James Monsees | Vaporizer apparatus |
| EP3821735A1 (en) | 2014-12-05 | 2021-05-19 | Juul Labs, Inc. | Calibrated dose control |
| WO2016133890A1 (en) * | 2015-02-19 | 2016-08-25 | Srq Patent Holdings, Llc | Compositions for e-cigarettes |
| MX2018009702A (es) | 2016-02-11 | 2019-07-08 | Juul Labs Inc | Cartucho rellenable de vaporizador y metodo de relleno. |
| BR112018016402B1 (pt) | 2016-02-11 | 2023-12-19 | Juul Labs, Inc | Cartuchos de fixação segura para dispositivos vaporizadores |
| US10405582B2 (en) | 2016-03-10 | 2019-09-10 | Pax Labs, Inc. | Vaporization device with lip sensing |
| USD849996S1 (en) | 2016-06-16 | 2019-05-28 | Pax Labs, Inc. | Vaporizer cartridge |
| USD848057S1 (en) | 2016-06-23 | 2019-05-07 | Pax Labs, Inc. | Lid for a vaporizer |
| USD851830S1 (en) | 2016-06-23 | 2019-06-18 | Pax Labs, Inc. | Combined vaporizer tamp and pick tool |
| USD836541S1 (en) | 2016-06-23 | 2018-12-25 | Pax Labs, Inc. | Charging device |
| USD887632S1 (en) | 2017-09-14 | 2020-06-16 | Pax Labs, Inc. | Vaporizer cartridge |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2463816A1 (fr) | 1979-08-24 | 1981-02-27 | Servimetal | Cartouche pour filtration active et traitement des metaux et alliages liquides |
| US4992271A (en) | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
| DE3621828A1 (de) | 1986-06-28 | 1988-01-14 | Biotest Pharma Gmbh | Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff |
| US5780012A (en) | 1990-06-21 | 1998-07-14 | Huland; Edith | Method for reducing lung afflictions by inhalation of cytokine solutions |
| EP0462305B1 (de) | 1990-06-21 | 1994-11-02 | Huland, Edith, Dr. Dr. | Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst |
| AU696387B2 (en) | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
| DE19811016A1 (de) | 1998-03-13 | 1999-09-16 | Dade Behring Marburg Gmbh | Gebrauchsfertiges Prothrombinzeitreagenz auf der Basis von rekombinantem Gewebsfaktor |
| CA2574970A1 (en) | 2004-07-30 | 2006-02-09 | Cel-Sci Corporation | A method for managing cholesterol with a serum-free and mitogen-free cytokine mixture |
| RU2290947C1 (ru) | 2005-10-27 | 2007-01-10 | Александр Иванович Воронов | Способ лечения опийной наркомании |
-
2011
- 2011-01-27 PT PT117054726T patent/PT2528617E/pt unknown
- 2011-01-27 DK DK11705472.6T patent/DK2528617T3/en active
- 2011-01-27 ES ES11705472.6T patent/ES2565486T3/es active Active
- 2011-01-27 EP EP11705472.6A patent/EP2528617B1/en active Active
- 2011-01-27 PL PL11705472.6T patent/PL2528617T3/pl unknown
- 2011-01-27 US US13/574,106 patent/US9028808B2/en active Active
- 2011-01-27 WO PCT/EP2011/051106 patent/WO2011092231A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| PL2528617T3 (pl) | 2016-09-30 |
| US9028808B2 (en) | 2015-05-12 |
| WO2011092231A1 (en) | 2011-08-04 |
| DK2528617T3 (en) | 2016-03-07 |
| EP2528617A1 (en) | 2012-12-05 |
| EP2528617B1 (en) | 2016-01-06 |
| US20130028861A1 (en) | 2013-01-31 |
| ES2565486T3 (es) | 2016-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2528617T3 (pl) | Interleukina-2 lub interferon-alfa do zastosowania w leczeniu uzależnienia od nikotyny lub jedzenia | |
| HK1224152A1 (zh) | 吸烟製品及其用於產生吸入物質的用途 | |
| HK1193324A1 (zh) | 吸烟物品過濾器和用於該過濾器的可***式過濾器單元 | |
| EP2789248A4 (en) | SMOKING ARTICLE AND FILTER | |
| HK1198110A1 (en) | Smoking article with front-plug and method | |
| ZA201207263B (en) | Smoking article | |
| SG10201500743TA (en) | Methods and systems for facilitating table games | |
| GB201021544D0 (en) | Smoking article | |
| EP2550879A4 (en) | SMOKING ARTICLE | |
| EP2608701A4 (en) | RETRACTABLE BELT FOR PACKAGING OF CUTLERY AND METHOD THEREFOR | |
| GB201013072D0 (en) | Smoking article | |
| ZA201108358B (en) | Smoking article | |
| EP2536293A4 (en) | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | |
| ZA201208316B (en) | Method for manufacturing smoking articles and smoking articles | |
| IL214500A0 (en) | Compositions and methods for extended therapy with aminopyridines | |
| PL2512273T3 (pl) | Element składowy wyrobu do palenia | |
| EP2648697A4 (en) | METHODS OF FORMING MINIEMULSIONS AND ASSOCIATED USE FOR ADMINISTRATION OF BIOACTIVE AGENTS | |
| GB201002083D0 (en) | Apparatus for improving and/or maintaining numerical ability | |
| PL2375888T3 (pl) | Filtr do stosowania przy przetwarzaniu środków spożywczych | |
| EP2540306A4 (en) | ADDITIVE TO A ERYTHROCYTE-RICH SOLUTION AND CONTAINER FOR MEDICAL PURPOSES | |
| GB0906187D0 (en) | Smoking article filter | |
| ZA201305086B (en) | Methods and compositions useful for promoting sleep in animals | |
| HK1199729A1 (en) | Aldh-2 inhibitors in the treatment of addiction aldh-2 | |
| GB201012732D0 (en) | Smoking article filter | |
| EP2498606A4 (en) | TIVOZANIB AND TEMSIROLIMUS IN COMBINATION |